Your Site
  • Home
  • Sleep Apnea Trials
  • Insomnia Trials
  • Narcolepsy Trials
  • Delayed Sleep-Wake Trial
  • More
    • Home
    • Sleep Apnea Trials
    • Insomnia Trials
    • Narcolepsy Trials
    • Delayed Sleep-Wake Trial
Your Site
  • Home
  • Sleep Apnea Trials
  • Insomnia Trials
  • Narcolepsy Trials
  • Delayed Sleep-Wake Trial

Phone: (726) 444-5237

Sleep Clinical Trials

Sleep Clinical TrialsSleep Clinical TrialsSleep Clinical Trials

Sleep Therapy & Research Center
5290 Medical Drive, 

San Antonio, Texas 78229
http://Sleep-Research.com

Phone: (726) 444-5237

Sleep Clinical Trials

Sleep Clinical TrialsSleep Clinical TrialsSleep Clinical Trials

Sleep Therapy & Research Center
5290 Medical Drive, 

San Antonio, Texas 78229
http://Sleep-Research.com

Current Clinical Trials

Narcolepsy Clinical Trial

Sleep Apnea Clinical Trial

Narcolepsy Clinical Trial

https://clinicaltrials.gov Trial #: NCT04794491

TITLE: An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy 

 

Brief Summary: 

The rationale for the interventional, open-label, single-arm design of JZP258-401 is to evaluate the clinical experience in participants with narcolepsy transitioning treatment from Xyrem to XYWAV.



INTERESTED? GO TO QUESTIONNAIRE

Narcolepsy Clinical Trial

Sleep Apnea Clinical Trial

Narcolepsy Clinical Trial

 INFO at: https://clinicaltrials.gov TITLES:  1)  A Multi-center, Randomized, Double-blind, Placebo-controlled, 3-Week Crossover Study to Assess the Efficacy and Safety of AXS-12 in Subjects With Cataplexy and Excessive Daytime Sleepiness in Narcolepsy - NCT03881852 2) A Double-blind, Randomized, Placebo Controlled, Two Arm Multi-center Study to Assess the Efficacy and Safety of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects With Narcolepsy - NCT02720744 3) A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients with Narcolepsy with and without Cataplexy 4) An Open Label Expanded Access Program Intended to Provide Treatment with HBS-101 (Pitolisant) to Adult Patients in the U.S. with Excessive Daytime Sleepiness Associated with Narcolepsy with or without Cataplexy

INTERESTED? GO TO QUESTIONNAIRE

Sleep Apnea Clinical Trial

Sleep Apnea Clinical Trial

Sleep Apnea Clinical Trial

INFO at: https://clinicaltrials.gov  Clinical Trial #: NCT PENDING

TITLE: COMING JUNE 2022

BRIEF: SLEEP APNEA WITH POSSIBLE WEIGHT REDUCTION USING A PHARMACOLOGIC AGENT


Apply - Insomnia Clinical Trial

Sleep Apnea Clinical Trial

Sleep Apnea Clinical Trial

Sleep Apnea Clinical Trial

INFO at: https://clinicaltrials.gov  Clinical Trial #: NCT104861038

Title:  Study Using Negative Pressure to Reduce Apnea (SUPRA)

Device: aerSleep II


Detailed Description:

This is a multi-center, single-arm, prospective, observational intervention study to determine the safety and effectiveness of the aerSleep II System. Up to 200 subjects will be enrolled at up to ten study sites in the United States to ensure that approximately 79 subjects who are termed initial responders can be evaluated after 24 weeks of home use with the aerSleep II device. As part of screening and prior to intervention, home sleep testing will be performed to establish baseline apnea-hypopnea index (AHI). Subjects meeting study criteria will wear the aerSleep II device at home. After a 1-week period of acclimation, subjects will have a second HST (HST #2). Initial responders with a ≥50% reduction in AHI from baseline with an AHI <20/hour will be continued on home treatment. Non-responders will be discontinued from the study. After 12 weeks, subjects will have an interim home sleep study. After 24 weeks of home use, subjects will have HST #4 to determine the primary effectiveness endpoint.

INTERESTED? GO TO QUESTIONNAIRE

Narcolepsy Clinical Trial

Sleep Apnea Clinical Trial

Narcolepsy Clinical Trial

INFO at: https://clinicaltrials.gov

Trial #: NCT PENDING

TITLE:  A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of TAK-861 in Healthy Adult and Elderly Subjects and Subjects With Narcolepsy Type 1

Copyright © 2022 Sleep Therapy & Research Center Clinical Studies - All Rights Reserved.

  • Home
  • Sleep Apnea Trials
  • Insomnia Trials
  • Narcolepsy Trials